Allogene Therapeutics
ALLO
ALLO
169 hedge funds and large institutions have $2.26B invested in Allogene Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 55 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
-12
Holders Change %
-6.63%
% of All Funds
2.97%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
18
Increased
54
Reduced
55
Closed
29
Calls
$2.18M
Puts
$4.17M
Net Calls
-$1.99M
Net Calls Change
-$2M
Top Buyers
| 1 |
CC
1
Casdin Capital
New York
|
$54M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$85.4M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$112M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$90.3M |
| 5 |
5
Ameriprise
Minneapolis,
Minnesota
|
$9.81M |
